Stock Market Analysis & Opinion

Yesterday saw markets undergo a period of introspection, as further positive news about the Pfizer (NYSE:PFE) vaccine offset concerns about the increasing economic damage set to be caused by further...

Stocks are higher as the vaccine race is heating up now that Pfizer (NYSE:PFE) and BioNTech confirmed their potential Covid-19 vaccine is 95% effective.Europe Early last week, the companies announced...

While lacking the same pizazz as previous vaccine updates, Pfizer’s latest titbit helped heft the markets a bit higher on Wednesday. After initially claiming that its preparation is 90%...

This week, the global markets are still forming a contradictory movement but with a rather stable sentiment. October's nationwide retail sales data from the United States, which were released on...

After years of repeatedly amazing skeptics on its potential as an electric car manufacturer, as well as its ability to deliver finished product and shareholder profitability, Elon Musk's Tesla...

After yesterday’s losses the markets weren’t up to much on Wednesday, taking a breather from their intense vaccine rally-and-retreat. Down 0.2%, the FTSE found itself sitting just below...

Shares in Character (LON:CCT) are currently trading at 374.4 but a key question for investors is how the economic uncertainty caused by Covid-19 will affect the price.Part of the answer comes down to...

The Covid-19 crisis has changed the outlook for companies across all industry sectors. For investors who own shares in them, the question now is whether these stocks are worth holding and where their...

Recent positive news about a COVID-19 vaccine has put the limelight on health-care and pharmaceutical companies, especially BioNTtech (NASDAQ:BNTX), Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE). Today,...

From a lowest ever trough, to a respectable two-year peak; 2020 has been quite a ride for the Royal Mail (LON:RMG) share price.Having hit record lows earlier this year of 120p, the Royal Mail share...

Reports Q3 2021 results on Wednesday, Nov. 18, after the close Revenue expectation: $4.41 billion EPS expectation: $2.57 NVIDIA Corp. (NASDAQ:NVDA) has emerged as the best-performing chip stock...

Remembering that the vaccine isn’t actually here just yet, the markets accelerated their retreat this Tuesday afternoon. Once again unable to make a lasting push above 30,000, the Dow Jones...

Stock markets are set to finish the session in the red as traders book their profits from yesterday’s impressive gains.Europe Dealers haven’t forgotten that Moderna’s possible...

After the decent vaccine inspired rally that we saw on Monday, markets in Europe had a slightly more tempered look to them on Tuesday as the continued rise in virus cases started to experience a bit...